Form D · Other Health Care

Visby Medical, Inc.

San Jose, CA · CIK 0001657186

Offering snapshot reported Mar 1, 2022 · SEC filing

Reported sold
$109M
Offering amount: $156M
Investors reported
45
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Feb 14, 2022
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 1, 2022Initial$108,621,185No comparison45SEC filing
May 14, 2019Initial$100,807,816No comparison101SEC filing
Jan 19, 2018Initial$9,520,000No comparison21SEC filing
Nov 5, 2015Initial$16,003,748No comparison30SEC filing

Offering details

Securities
Equity, Other
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-435400
Series E Preferred Stock and Common Stock issuable upon conversion

Source: Form D, filed Mar 1, 2022. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Jerome Behar Director
Terri Bresenham Director
Adam De La Zerda Director, Executive
David Engman Director
Mark Ibison Executive
John Kuo Executive
Gregory Loney Executive
Shlomo Melmed Director
Scott E. Mendel Director
Eric Moessinger Director
Thomas M. Prescott Director
Steven Rosston Director
Amit Shah Director
Ajit Singh Director, Executive

Issuer details

Industry: Other Health Care (See others in industry)

Address:
3010 N. 1 St Street
San Jose, CA, 95134